Aprea Therapeutics Inc.

(APRE) Trade

Symbol has changed to a new ticker symbol

(APRED)

By |

Profile

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Contact Information

Website: www.aprea.com
Email: chris.schade@aprea.com
Main Phone: +1 617 463-9385
Address: 535 Boylston Street
Address 2: Suite 170
State: MA
City / Town: Boston
Country: USA
Postal Code: 02116

Issuer Information

Exchange: NGS
CEO: Christian S. Schade
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Contact Information

Website: www.aprea.com
Email: chris.schade@aprea.com
Main Phone: +1 617 463-9385
Address: 535 Boylston Street
Address 2: Suite 170
State: MA
City / Town: Boston
Country: USA
Postal Code: 02116

Issuer Information

Exchange: NGS
CEO: Christian S. Schade
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 26.56 $ 0.38 (1.45%)
Last Price 26.56 Change $ 0.38 Change % 1.45 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 26.63 High 26.97 Low 25.65 Prev Close 26.18
Last Trade Volume 104,843 52 Wk Hi 53.12 52 Wk Low 15.11
Market Cap 559.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,054,842.00 EPS (TTM) -5.04 PE Ratio N/A Exchange NGS